Pure Performance 100% Clean Mass Gainer Chocolate Flavour
Natural health product licensed in Canada
- Licence holder
- Wellnx Life Sciences Inc./ Altrex Nutrition/ Wellnx Distribution Inc.
- NPN or DIN-HM
- 80087100
- Status
- Active licence
- Licence date
- 16 July 2018
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Medicago sativa Source : Sommité | 0.375 mg | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 2.25 mg | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 112.25 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| Concentré de protéine de lactosérum Source : Bos taurus - Lait Potency : 85 % Whey protein | 4.27 g | Not calculated |
| Protéine de pois Source : Protéine de pois Potency : 80 % Protein | 2.75 g | Not calculated |
| N-(Aminoiminométhyl)-N-méthylglycine monohydraté Source : Créatine monohydratée | 0.75 g | Not calculated |
| Maltodextrine Source : Maltodextrin | 32.125 g | Not calculated |
| Linum usitatissimum Source : Graine(s) | 2.25 mg | Not calculated |
| Extrait de fève de café vert Source : Coffea canephora - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 450 mg Potency : 45 % Chlorogenic acids | 45 mg | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BL-04 | 0.1125 mg | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 0.1125 mg | Not calculated |
| Lactobacillus acidophilus Source : LA-14 | 0.275 mg | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 0.275 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 2.25 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 2.25 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 0.45 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 0.45 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 0.015 mg | Not calculated |
| Papaïne Source : Carica papaya - fruit | 33.75 mg | Not calculated |
| Isolat de protéine de lactosérum Source : Bos taurus - Lait Potency : 90 % Whey protein | 4.3 g | Not calculated |
| Hydrolysat de protéine du lactosérum Source : Bos taurus - Lait Potency : 75 % Whey protein | 0.6 g | Not calculated |
| Isolat de protéine de lait Source : Bos taurus - Lait Potency : 80 % Protein | 0.475 g | Not calculated |
| Isolat de protéine de boeuf Source : Bos taurus - Muscle Potency : 95 % Protein | 0.475 g | Not calculated |
| Micelles de caséine Source : Bos taurus - Lait Potency : 81 % Protein | 118.5 mg | Not calculated |
| Micelles de caséine Source : Micellar casein Potency : 81 % Protein | 118.5 mg | Not calculated |
| Caséinate de calcium Source : Bos taurus - Lait Potency : 88.5 % Protein | 116.75 mg | Not calculated |
| Colostrum bovin Source : Bos taurus - colostrum | 9.5 mg | Not calculated |
| Caséine, sel de sodium Source : Sodium caseinate Potency : 85 % Protein | 9.5 mg | Not calculated |
| Caséine, sel de sodium Source : Bos taurus - Lait Potency : 85 % Protein | 9.5 mg | Not calculated |
| Astragalus membranaceus Source : Racine | 8.5 mg | Not calculated |
| Panax notoginseng Source : Racine | 8.5 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 1.125 FCC LU | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BL-04 | 0.055 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 0.055 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : LA-14 | 0.055 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 0.055 Milliards d'UFC | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 11.25 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 11.25 FCC CU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 33.75 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 33.75 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| Papaïne Source : Carica papaya - fruit | 2,506.5 Unités de papaïne du FCC | Not calculated |
Non-medicinal ingredients
Poudre de germe de quinoa, Gomme de Guar, Millet, Extrait de fruit de monk, Maltodextrine, Dioxyde de silicium, Poudre de germe de sarrasin, Chlorure de sodium, Son d'Avena sativa (Avoine), Saveur de chocolat, Poudre de cacao, Sucralose, Albumen, Feuille de Stevia rebaudiana, Mélange de germes, Saveur de vanille, Poudre de germe d'amaranthe, Acacia, Gomme de xanthane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 4 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Increases muscle size when used in conjunction with a resistance training regimen. Improves strength and power in repetitive bouts of brief, highly-intense physical activity. Source of calories which contributes to weight gain. Source of carbohydrates to support energy production. Helps to [maintain performance/promote endurance] in extended (greater than 60 min), high intensity exercise. Source of (all) essential amino acids (i.e. histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine) for the maintenance of good health. Source of branched chain amino acids for the maintenance of good health. Source of (essential) amino acids involved in muscle protein synthesis. (Excellent) Source of protein for the maintenance of good health. (Excellent) Source of protein which helps build and repair body tissues. (Excellent) Source of protein which helps build antibodies. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet. Source of digestive enzymes. Source of enzymes that help digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087100
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Medicago sativa
Read the warning, when it applies and the studies cited
ALFALFA - MEDICAGO SATIVA
Route of administration: Oral
Cautions and warnings
Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.
Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Linum usitatissimum
Read the warning, when it applies and the studies cited
FLAXSEED - LINUM USITATISSIMUM
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Astragalus membranaceus
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.